CN106604929B - 新型过敏原 - Google Patents

新型过敏原 Download PDF

Info

Publication number
CN106604929B
CN106604929B CN201580038584.4A CN201580038584A CN106604929B CN 106604929 B CN106604929 B CN 106604929B CN 201580038584 A CN201580038584 A CN 201580038584A CN 106604929 B CN106604929 B CN 106604929B
Authority
CN
China
Prior art keywords
protein
equ
ige
horse
allergy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201580038584.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN106604929A (zh
Inventor
L.马特斯森
U.奥斯森
T.伦德格伦
J.里德霍尔姆
H.拉斯森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phadia AB
Original Assignee
Phadia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phadia AB filed Critical Phadia AB
Publication of CN106604929A publication Critical patent/CN106604929A/zh
Application granted granted Critical
Publication of CN106604929B publication Critical patent/CN106604929B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN201580038584.4A 2014-07-21 2015-07-20 新型过敏原 Active CN106604929B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1450907-9 2014-07-21
SE1450907 2014-07-21
PCT/SE2015/050828 WO2016013971A1 (en) 2014-07-21 2015-07-20 Novel allergen

Publications (2)

Publication Number Publication Date
CN106604929A CN106604929A (zh) 2017-04-26
CN106604929B true CN106604929B (zh) 2021-11-05

Family

ID=53872123

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580038584.4A Active CN106604929B (zh) 2014-07-21 2015-07-20 新型过敏原

Country Status (10)

Country Link
US (1) US10753946B2 (enExample)
EP (1) EP3171890B1 (enExample)
JP (1) JP6785216B2 (enExample)
CN (1) CN106604929B (enExample)
AU (1) AU2015294723B2 (enExample)
CA (1) CA2955348A1 (enExample)
DK (1) DK3171890T3 (enExample)
ES (1) ES2856128T3 (enExample)
RU (1) RU2017104910A (enExample)
WO (1) WO2016013971A1 (enExample)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011133105A1 (en) * 2010-04-23 2011-10-27 Phadia Ab Novel allergen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6019972A (en) * 1989-11-03 2000-02-01 Immulogic Pharmaceutical Corporation Peptides of human T cell reactive feline protein (TRFP)
EP1195606A1 (en) 2000-10-03 2002-04-10 VBC-Genomics Forschungsges.m.b.H. Allergen-microarray assay

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011133105A1 (en) * 2010-04-23 2011-10-27 Phadia Ab Novel allergen
CN103108883A (zh) * 2010-04-23 2013-05-15 法蒂亚公司 新型变应原

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Cabañas R等.Importance of albumin in cross-reactivity among cat,dog and horse allergens.《Journal of Investigational Allergology and Clinical Immunology》.2000, *
Predicted: major allergen I polypeptide chain 1-like [Equus przewalskii];GenBank;《GenBank Database》;20140714;Accession NO.XP_008513295.1 *
Predicted: major allergen I polypeptide chain 2-like isoform X1[Equus przewalskii];GenBank;《GenBank Database》;20170714;Accession NO.XP_008513296.1 *
马主要过敏原Equ c1的重组表达及其低过敏原性的改造;彭俊玲;《中国优秀硕士学位论文全文数据库医药卫生科技辑》;20121015;E059-185 *

Also Published As

Publication number Publication date
CA2955348A1 (en) 2016-01-28
EP3171890A1 (en) 2017-05-31
US10753946B2 (en) 2020-08-25
AU2015294723A1 (en) 2017-02-16
CN106604929A (zh) 2017-04-26
JP2017524358A (ja) 2017-08-31
DK3171890T3 (da) 2021-02-22
US20170219602A1 (en) 2017-08-03
WO2016013971A1 (en) 2016-01-28
EP3171890B1 (en) 2020-12-02
ES2856128T3 (es) 2021-09-27
RU2017104910A (ru) 2018-08-21
JP6785216B2 (ja) 2020-11-18
AU2015294723B2 (en) 2021-05-06

Similar Documents

Publication Publication Date Title
US9274114B2 (en) Prostate kallikrein allergen
US20220241406A1 (en) Novel allergen
CN106604929B (zh) 新型过敏原
US9724407B2 (en) Horse allergen and methods
RU2592674C2 (ru) Аллергены, полученные рекомбинантными способами

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant